Story Created: Aug 9, 2013 at 1:18 PM EDT Story Updated: Aug 9, 2013 at 2:08 PM EDT The Oneida County Health Department today confirmed that a horse living on a farm in Vernon has been infected with West Nile encephalitis, an inflammation of the central nervous system, which is caused by infection with West Nile Virus (WNV). They say the yearling, one of several horses on the property, first displayed symptoms last week and was eventually paralyzed in the hind limbs. A positive confirmation of West Nile Virus was made earlier in the week. The horse has shown improvement and is standing following supportive veterinarian care, though he is still displaying some residual ataxia in the hind legs. None of the other horses on the farm have shown signs of the disease. The affected animal had no history of travel and is in no way connected to nearby Vernon Downs Raceway, according to health department officials. According to Oneida County Health Department officials, an animal can become infected with West Nile Virus after being bitten by certain species of mosquitoes which have been infected with the disease. Animals cannot transmit WNV to other animals or humans. The Oneida County … Continue reading →

Public School Supporter Hollywood Hypocrite Matt Damon sends kids to private school Matt Damon, whose mom is a public school teacher, has long been a vocal advocate of public schools. And yet, as he moves to LA, he's sending his four daughte... By: LSUDVM … Continue reading →

Chance Therapy (3) 8/5/13 The water therapy begins. This is where my phone went bonkers, sorry! By: BarknRest … Continue reading →

Aug. 10, 2013 A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer cells. The research team developing the drug -- led by scientists at the Nanomedicine Research Center, part of the Maxine Dunitz Neurosurgical Institute in the Department of Neurosurgery at Cedars-Sinai Medical Center -- conducted the study in laboratory mice with implanted human breast cancer cells. Mice receiving the drug lived significantly longer than untreated counterparts and those receiving only certain components of the drug, according to a recent article in the Journal of Controlled Release. Researchers from the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, the Division of Surgical Oncology at UCLA, and the Molecular Biology Institute at UCLA also participated in the study. Unlike other drugs that target cancer cells from the outside, often injuring normal cells as a side effect, this therapy consists of multiple drugs chemically bonded to a "nanoplatform" that functions as a transport vehicle. HER2-positive cancers -- making up 25 to 30 percent of breast and ovarian cancers -- tend to be more … Continue reading →

Dallas, TX (PRWEB) August 10, 2013 This report forecasts the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also witnessed the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market. Get a copy of this report at http://www.rnrmarketresearch.com/global-nanomedicine-market-2012-2016-market-report.html. This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc. The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences Inc., IDEX Corp., IGI Laboratories … Continue reading →